Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Zhiguang Zhou"'
Publikováno v:
Journal of Diabetes, Vol 15, Iss 9, Pp 787-798 (2023)
Abstract Background This retrospective multicenter study evaluated the efficacy and safety of bariatric surgery in Chinese patients with obesity. Methods Patients with obesity who underwent laparoscopic sleeve gastrectomy or laparoscopic Roux‐en‐
Externí odkaz:
https://doaj.org/article/dc94df5b244747f8b33e6660f76a07f3
Autor:
Sihui Luo, Xingwu Ran, Mei Zhang, Ji Hu, Daizhi Yang, Dalong Zhu, Jiajun Zhao, Xinhua Xiao, Xiaohui Guo, Tao Yang, Qin Huang, Fang Liu, Lu Jing, Jing Ma, Xinli Zhou, Fan Ping, Nan Gu, Wenwen Li, Yaling Yang, Chen Fang, Wei Bao, Xueying Zheng, Jinhua Yan, Zhiguang Zhou, Jianping Weng
Publikováno v:
Journal of Diabetes, Vol 14, Iss 1, Pp 5-14 (2022)
Abstract Background We aimed to report pregnancy outcomes of women with type 1 diabetes (T1D) in China, on which data were sparse. Methods This is a nationwide retrospective study conducted in 11 general medical centers in 8 cities across China. We i
Externí odkaz:
https://doaj.org/article/99f88bfca36446a5a26cc522fbdf4fa9
Autor:
Linong Ji, Juming Lu, Yan Gao, Chang-yu Pan, Wenying Yang, Xiaohui Guo, Leili Gao, Xian Li, Yangfeng Wu, Puhong Zhang, Zhiguang Zhou, Jianping Weng, Dajin Zou, Weiping Jia, Dongshan Zhu, Satish K. Garg
Publikováno v:
Journal of Diabetes. 12:668-676
The efficacy of basal insulin (BI) for adequate glycemic control in patients with type 2 diabetes mellitus (T2DM) has been well documented by randomized clinical trials. This post hoc analysis of the Observational Registry of Basal Insulin Treatment
Publikováno v:
Journal of Diabetes. 12:761-768
Partial remission (PR) is a special stage in type 1 diabetes (T1D). The different patterns of PR frequency, characteristics, and determinants in juvenile and adult patients are unclear, and data on Chinese are lacking.A total of 186 children and 114
Autor:
Daizhi Yang, Lu Jing, Xing-Wu Ran, Wei Bao, Yaling Yang, Jing Ma, Xueying Zheng, Tao Yang, Fan Ping, Ji Hu, Xinli Zhou, Fang Liu, Dalong Zhu, Xiaohui Guo, Xinhua Xiao, Qin Huang, Wenwen Li, Nan Gu, Zhiguang Zhou, Chen Fang, Mei Zhang, Jinhua Yan, Jianping Weng, Jiajun Zhao, Sihui Luo
Publikováno v:
Journal of diabetes. 14(1)
We aimed to report pregnancy outcomes of women with type 1 diabetes (T1D) in China, on which data were sparse.This is a nationwide retrospective study conducted in 11 general medical centers in 8 cities across China. We investigated the clinical data
Autor:
Dalong Zhu, Hong Li, Zhengnan Gao, Guijun Qin, Longyi Zeng, Jiajun Zhao, Qiang Li, Dajin Zou, Xiaohui Guo, Jianping Weng, Zhiguang Zhou, Nan Cui, Nanwei Tong, Lulu Chen, Juming Lu, Liyong Yang, Yiming Li, Jun Zhu, Qiuhe Ji, Qifu Li, Ping Feng, Tianhong Luo
Publikováno v:
Journal of Diabetes
Background Because there has been no quality improvement initiatives targeting patients with type 2 diabetes (T2D) receiving basal insulin therapy, this study evaluated the effectiveness of physician‐targeted education for optimizing glycemic manag
Autor:
Weili Tang, Xiaoyu Xiao, Zhiguang Zhou, Shiping Liu, Zhiguo Xie, Long Li, Hou-De Zhou, Lili Liu, Yang Xiao
Publikováno v:
Journal of Diabetes. 11:83-86
Highlights This study reports a novel frameshift mutation c.212dupG (p.Gly73fs) in the insulin (INS) gene causing maturity onset diabetes of the young (MODY) 10, one of the rare types of MODY, identified in seven family members. Screening for mutatio
Autor:
Xia Li, Xiongzhao Zhu, Zhiguang Zhou, Yuting Xie, H.G. Zheng, Xiang Yan, Fang Liu, Shichen Li, Jing He
Publikováno v:
Journal of Diabetes. 10:948-957
BACKGROUND Type 1 diabetes mellitus (T1DM) is considered a risk factor for the development of cognitive difficulties. The present study examined whether the cognitive performance of Chinese children with T1DM differs from that of healthy control (HC)
Autor:
Yiming Li, Jianhua Ma, Jae Hyeon Kim, Agata Ptaszynska, Wenying Yang, June Zhao, Zhiguang Zhou, Yanbing Li
Publikováno v:
Journal of Diabetes. 10:589-599
BACKGROUND This 24-week Phase 3 double-blind placebo-controlled study assessed the safety and efficacy of dapagliflozin as add-on to insulin, with or without oral antihyperglycemic drugs (OADs), in Asian patients with inadequately controlled type 2 d
Autor:
Linong Ji, Wenying Yang, Zhiguang Zhou, Valerie A. Cain, Kristina Johnsson, C. David Sjöström
Publikováno v:
Journal of Diabetes. 9:787-799
Background The efficacy and safety of dapagliflozin, a sodium–glucose cotransporter 2 inhibitor, has been demonstrated predominantly in Western populations. This study examined the efficacy and safety of dapagliflozin in Asian patients with type 2